Tower Research Capital (TRC)’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.5K | Sell |
|
|||||
|
2025
Q2 | $22.5K | Buy |
|
|||||
|
2025
Q1 | $13.2K | Sell |
|
|||||
|
2024
Q4 | $37.8K | Buy |
|
|||||
|
2024
Q3 | $9.85K | Sell |
|
|||||
|
2024
Q2 | $50.3K | Buy |
|
|||||
|
2024
Q1 | $3.68K | Sell |
|
|||||
|
2023
Q4 | $44K | Sell |
|
|||||
|
2023
Q3 | $82.2K | Buy |
|
|||||
|
2023
Q2 | $11.4K | Sell |
|
|||||
|
2023
Q1 | $18K | Buy |
|
|||||
|
2022
Q4 | $11K | Sell |
|
|||||
|
2022
Q3 | $121K | Buy |
|
|||||
|
2022
Q2 | $70K | Buy |
|
|||||
|
2022
Q1 | $37K | Buy |
|
|||||
|
2021
Q4 | $9K | Sell |
|
|||||
|
2021
Q3 | $31K | Buy |
|
|||||
|
2021
Q2 | $9K | Buy |
|